Primary ER-positive Breast Cancer Treated with Neoadjuvant Letrozole
收藏NIAID Data Ecosystem2026-05-16 收录
下载链接：
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000857.v1.p1
下载链接
链接失效反馈官方服务：
资源简介：
These are tumor biopsies and corresponding normal samples from patients with early stage ER+/HER2- breast cancer who had received the aromatase inhibitor letrozole for 10-21 days prior to surgery.]]>
All patients had early stage ER+/HER2- breast cancer and participated in a clinical trial of neoadjuvant letrozole for 10-21 days prior to surgery.]]>
创建时间：
2015-04-27
